Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-26
1997-10-07
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540490, 540552, 540523, 540580, 540593, 540495, 540506, 540493, 540504, 540512, 514215, 514219, 514220, 514221, C07D28536, C07D51304, A61K 3155
Patent
active
056748639
ABSTRACT:
A benzodiazepinedione derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
REFERENCES:
patent: 3371085 (1968-02-01), Reeder et al.
patent: 3374264 (1968-03-01), Uskokovic et al.
patent: 3415814 (1968-12-01), Carabateas
patent: 3551414 (1970-12-01), Hawthorne et al.
patent: 3721666 (1973-03-01), Weber et al.
patent: 4689326 (1987-08-01), Hall et al.
patent: 5055464 (1991-10-01), Murakami et al.
patent: 5061693 (1991-10-01), Nutt et al.
patent: 5063225 (1991-11-01), Clemence et al.
patent: 5082937 (1992-01-01), Calvet et al.
patent: 5141930 (1992-08-01), Nakao et al.
Bellamy et al., "Selective Reduction of Aromatic Nitro Compounds with Stannous Chloride in Non Acidic and Non Aqueous Medium" Tetrahedron Letters 25(8):839-842 (1984).
Boehringer et al., "1-Phenyl-4-alkyl-3H-1,4-benzodiazepine-2, 5-(1H-4H)-diones" Chemical Abstracts 79:460 (Abstract No. 18778a, 1973).
Carabateas, P., "4-Cyclopropylmethyl-3H-1,4-benzodiazepine-2, 5(1H,4H)-dione" Chemical Abstracts 70:348 (Abstract No. 47513e, 1969). 5,5-dioxide derivatives" Chemical Abstracts 79:356 (Abstract No. 115543c, 1973).
Coppola, G., "The Chemistry of Isatoic Anhydride" Synthesis pp. 505-536 (1980).
Griot, R., "3H-1,4-Benzodiazepin-2-1H-ones" Chemical Abstracts 70:348 (Abstract No. 47512d, 1969).
Kappe et al., "Isatoic Anhydrides and Their Uses in Heterocyclic Synthesis" Advances in Heterocyclic Chemistry 28:127-182 (1981).
Kim et al., "Monosubstituted Guanidines from Primary Amines and Aminoiminomethenesulfonic Acid" Tetrahedron Letters 29(26):3183-3186 (1988).
Kukla et al., "Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo 34:3187-3197 (1991).
Lee, C., "Synthesis of 1-Methyl-3H-1,4-benzodiazepine-2,5 (1H,4H)-dione and Derivatives" J. Heterocyclic Chem. 1:235-238 (Dec. 1964).
Levai et al., "Oxazepines and Thiazepines. IV. Synthesis of 2,3-dihydro-2-phenyl-1,4-benzoxazepine Derivatives" Chemical Abstracts 90:586 (Abstract No. 6376g 1979).
Murai et al., "Cobalt Carbonyl Catalyzed Reduction of Aromatic Nitriles with a Hydrosilane Leading to N,N-Disilylamines" Tetrahedron Letters 26(42):5145-5148 (1985).
Nagarajan et al., "Condensed Heterotricycles: Potential Metabolites of Chemistry 12:270-274 (Mar. 1974).
Oine et al., "1,4-Benzodiazepine Derivatives" Heterocycles 81:473 (Abstract No. 91597m 1974).
Shirai et al., "Syntheses of heterocyclic compounds involving sulfur. III. Synthesis of ne" Chemical Abstracts 76:318 (Abstract No. 34228g, 1972).
Shirai et al., "Synthesis of Abstracts 77:444 (Abstract No. 140001r, 1972). Abstracts 70:348-349 (Abstract No. 47516h, 1969).
Venuti, M., "Isatoic Anhydride/4-Dimethylaminopyridine as a Reagent for Ortho-Aminobenzoylation" Synthesis 4:266-268 (Apr. 1982).
Voorstad et al., "Comparison of the Hypolipidemic Activity of Cyclic vs. Acyclic Imides" J. Med. Chem. 28(1):9-12 (1985).
Watjen et al., "Novel Benzodiazepine Receptor Partial Agonists: Oxadiazolylimidazobenzodiazepines" J. Med. Chem. 32:2282-2291 (1989).
Barker Peter
Blackburn Brent
Gadek Thomas
McDowell Robert
McGee Lawrence
Genentech Inc.
Shah Mukund J.
Winter Daryl B.
Wong King Lit
LandOfFree
Nonpeptidyl integrin inhibitors having specificity for the GPII. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonpeptidyl integrin inhibitors having specificity for the GPII., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonpeptidyl integrin inhibitors having specificity for the GPII. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357531